1. Home
  2. CYPH vs PCLA Comparison

CYPH vs PCLA Comparison

Compare CYPH & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cypherpunk Technologies Inc.

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$2.43

Market Cap

73.3M

Sector

Health Care

ML Signal

HOLD

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$7.42

Market Cap

81.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
PCLA
Founded
2011
2008
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
73.3M
81.6M
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
CYPH
PCLA
Price
$2.43
$7.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.7M
296.2K
Earning Date
05-13-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
103.87
N/A
EPS
N/A
N/A
Revenue
$1,500,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.12
52 Week High
$3.70
$19.61

Technical Indicators

Market Signals
Indicator
CYPH
PCLA
Relative Strength Index (RSI) 80.38 56.63
Support Level $0.69 $6.10
Resistance Level N/A $7.50
Average True Range (ATR) 0.34 1.07
MACD 0.11 -0.10
Stochastic Oscillator 69.43 20.29

Price Performance

Historical Comparison
CYPH
PCLA

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: